Therapy of non-small cell lung cancer in stage IV

被引：1
|
作者：
Deppermann, Karl-Matthias [1 ]
Huber, Rudolf M.
Laack, Eckart
Reck, Martin
Serke, Monika
von Pawel, Joachim
机构：
[1] Ruppiner Klinikum GmbH, Klin Pneumol, Neuruppin, Germany
[2] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Med Klin 2, Hamburg, Germany
[4] Krankenhaus Grosshansdorf, Zentrum Pneumol & Thoraxchirurg, D-2070 Grosshansdorf, Germany
[5] Helios Klinikum Emil von Behring, Klin Pneumol 2, Lungenklin Heckeshorn, Berlin, Germany
[6] Asklepios Fachkliniken Munchen Gauting, Schwerpunkt Onkol, Gauting, Germany
来源：
ONKOLOGIE | 2006年 / 29卷
关键词：
NSCLC; pharmacology; erlotinib; combination therapy; single agent therapy;
D O I：
10.1159/000094950
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：15 / 19
页数：5
相关论文
共 50 条
  • [21] Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
    Thatcher, Nicholas
    Heighway, Jim
    ONCOLOGIST, 2010, 15 (10): : 1034 - 1042
  • [22] A Case of Stage IV Non-Small Cell Lung Cancer Treated with Korean Medicine Therapy Alone
    Lee, Dong-hyun
    Seong, Shin
    Kim, Sung-su
    Han, Jae-bok
    CASE REPORTS IN ONCOLOGY, 2013, 6 (03): : 574 - 578
  • [23] Multimodality therapy in stage III non-small cell lung cancer
    Edelman, MJ
    Gandara, DR
    Roach, M
    Benfield, JR
    ANNALS OF THORACIC SURGERY, 1996, 61 (05): : 1564 - 1572
  • [24] Targeted Therapy in Early Stage Non-small Cell Lung Cancer
    Liu, Si-Yang
    Liu, Si-Yang Maggie
    Zhong, Wen-Zhao
    Wu, Yi-Long
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1169 - 1184
  • [25] Targeted Therapy in Early Stage Non-small Cell Lung Cancer
    Si-Yang Liu
    Si-Yang Maggie Liu
    Wen-Zhao Zhong
    Yi-Long Wu
    Current Treatment Options in Oncology, 2022, 23 : 1169 - 1184
  • [26] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer
    Besse, Benjamin
    Garrido, Pilar
    Cortot, Alexis B.
    Johnson, Melissa
    Murakami, Haruyasu
    Gazzah, Anas
    Gil, Maciej
    Bennouna, Jaafar
    LUNG CANCER, 2020, 142 : 63 - 69
  • [27] MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
    Bento, Daniela
    Almeida, Jani Sofia
    Couceiro, Patricia
    Alves, Vera
    Santos-Rosa, Manuel
    Barata, Fernando Jose
    Rodrigues-Santos, Paulo
    Ferreira Rodrigues Figueiredo, Ana Maria
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [28] Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?
    Hendriks, Lizza E. L.
    Dingemans, Anne-Marie C.
    LUNG CANCER, 2019, 129 : 95 - 97
  • [29] Compliance with ASCO guidelines in the treatment of stage IV non-small cell lung cancer
    Marr, A. S.
    Loberiza, F. R.
    Kessinger, M. A.
    McGarry, J.
    Ganti, A. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Stroke And A Valvular Lesion In A Patient With Stage Iv Non-Small Cell Lung Cancer
    Mitma, A. A.
    Zarich, S.
    Witt, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345